Torrent Pharma slips over 3.25% after its Gujarat facility receives Form 483 with 5 observations from US FDA

Torrent Pharma share price: Torrent Pharmaceuticals Ltd fell over 3.25 per cent on BSE on Thursday (June 13, 2024) as the manufacturing facilities of the Gujarat-based large-cap company received Form 483 with five observations from the Drug Administration and United States Foods (US FDA).

Shares of Torrent Pharmaceuticals that closed trading at Rs 2,894.45 each a day ago fell 3.26 per cent to Thursday's low of Rs 2,800.05 each.

Shares of Torrent Pharmaceuticals were trading down 0.88 per cent, or Rs 25.55, at Rs 2,868.90 at 9:50 am on Thursday.

The stock fell a day after the company hit its 52-week high of Rs 2,919.95.

Torrent Pharmaceuticals on Wednesday said its Indrad, Gujarat-based manufacturing facility had received Form 483 from the US FDA.

The pharmaceutical company said the US FDA had conducted a pre-approval inspection (PAI) and GMP inspection at its manufacturing facility in Indrad, Gujarat, from June 3 to 12.


Leave a Comment

Comments

No comments yet. Why donโ€™t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *